Peregrine Capital Management’s BioLife Solutions BLFS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.52M	Sell	341,847 -14,496	-4%	-$320K	0.24%	124
2025 Q4	$8.62M	Sell	356,343 -4,799	-1%	-$126K	0.26%	106
2025 Q3	$9.21M	Sell	361,142 -9,521	-3%	-$226K	0.28%	96
2025 Q2	$7.98M	Buy	370,663 +6,217	+2%	+$140K	0.24%	116
2025 Q1	$8.32M	Buy	364,446 +12,241	+3%	+$322K	0.28%	96
2024 Q4	$9.14M	Buy	352,205 +54,100	+18%	+$1.35M	0.27%	90
2024 Q3	$7.46M	Buy	298,105 +649	+0.2%	+$15.3K	0.23%	116
2024 Q2	$6.37M	Buy	297,456 +3,869	+1%	+$75.1K	0.19%	192
2024 Q1	$5.45M	Buy	293,587 +100	+0%	+$1.75K	0.16%	228
2023 Q4	$4.77M	Sell	293,487 -50,663	-15%	-$646K	0.14%	232
2023 Q3	$4.75M	Sell	344,150 -21,611	-6%	-$341K	0.14%	234
2023 Q2	$8.08M	Sell	365,761 -113	-0%	-$2.38K	0.22%	192
2023 Q1	$7.96M	Buy	365,874 +80,226	+28%	+$1.8M	0.23%	193
2022 Q4	$5.2M	Sell	285,648 -8,646	-3%	-$179K	0.16%	231
2022 Q3	$6.7M	Sell	294,294 -16,276	-5%	-$348K	0.22%	210
2022 Q2	$4.29M	Sell	310,570 -232	-0.1%	-$3.4K	0.13%	245
2022 Q1	$7.07M	Sell	310,802 -22,277	-7%	-$586K	0.17%	230
2021 Q4	$12.4M	Buy	+333,079	New	+$14.3M	0.25%	144